It appears no script is enabled within your browser. Please enable JavaScript to use this site.
Skip header and navigation
Home
View Selections:
0
Items
Help
Print
[Cholesterol lowering therapy after myocardial infarction. Consequences of the CARE study]
https://arctichealth.org/en/permalink/ahliterature54500
Source
Tidsskr Nor Laegeforen. 1997 Jun 20;117(16):2341-4
Publication Type
Article
Date
Jun-20-1997
More detail
Author
J E Otterstad
E. Hexeberg
I. Holme
I. Hjermann
Author Affiliation
Hjerteseksjonen, Vestfold Sentralsykehus, Tønsberg.
Source
Tidsskr Nor Laegeforen. 1997 Jun 20;117(16):2341-4
Date
Jun-20-1997
Language
Norwegian
Publication Type
Article
Keywords
Adult
Aftercare
Aged
Anticholesteremic Agents - administration & dosage
Cause of Death
English Abstract
Female
Follow-Up Studies
Humans
Male
Middle Aged
Myocardial Infarction - mortality - prevention & control
Norway - epidemiology
Pravastatin - administration & dosage
Recurrence
Abstract
In the recently published CARE-study, 4,159 patients aged 21-75 years were included and randomised to treatment with pravastatin 40 mg once daily or placebo 3-20 months following a myocardial infarction. Inclusion criteria were a total cholesterol
PubMed ID
9265282
View in PubMed
Less detail
Permalink